Flamel Takes Lupin To Court Over Generic Coreg
Flamel Technologies SA filed a patent infringement suit against Lupin Ltd. in Washington on Wednesday over the Indian drug manufacturer's abbreviated new drug application for a generic version of heart-failure treatment...To view the full article, register now.
Already a subscriber? Click here to view full article